⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
NAGE News
Niagen Bioscience, Inc. Common Stock
Niagen Bioscience to Present at the 38th Annual ROTH Conference
businesswire.com
NAGE
Niagen Bioscience Surpasses 300 External Research Agreements from Leading Global Institutions on Niagen ®, Contributing to 45 Published Clinical Studies
businesswire.com
NAGE
Niagen Bioscience Launches Niagen ® Skincare Innovation Lab and Debuts Dermatologist-Tested Niagen NanoCloud™, From Tru Niagen Powered by Patented Niagen ®
businesswire.com
NAGE
Niagen Bioscience Reports 30% Year-Over-Year Net Sales Increase to $129.4 million, 103% Net Income Increase to $17.4 million or $0.22 Basic EPS in 2025
businesswire.com
NAGE
Niagen Bioscience Reports 30% Year-Over-Year Net Sales Increase to $129.4 million, 103% Net Income Increase to $17.4 million or $0.22 Basic EPS in 2025
businesswire.com
NAGE
Niagen Bioscience Reports 30% Year-Over-Year Net Sales Increase to $129.4 million, 103% Net Income Increase to $17.4 million or $0.22 Basic EPS in 2025
businesswire.com
NAGE
Form 8-K
sec.gov
NAGE
Investors Eye Explosive Growth in Anti-Aging Therapies as Market Targets $420B Milestone
prnewswire.com
NAGE
OCGN
NTLA
GERN
Form 8-K
sec.gov
NAGE
Niagen Bioscience to Streamline and Focus its Operations with the Sale of ChromaDex Reference Standards Business to LGC in All-Cash Transaction
businesswire.com
NAGE